These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20025499)

  • 21. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection.
    Steinberg MW; Huang Y; Wang-Zhu Y; Ware CF; Cheroutre H; Kronenberg M
    PLoS One; 2013; 8(10):e77992. PubMed ID: 24205057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity.
    del Rio ML; Kurtz J; Perez-Martinez C; Ghosh A; Perez-Simon JA; Rodriguez-Barbosa JI
    Transplantation; 2011 Nov; 92(10):1085-93. PubMed ID: 21978997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
    Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
    J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of monoclonal antibodies in a sandwich enzyme-linked immunosorbent assay for identification and detection of soluble human B and T lymphocyte attenuator.
    Wang X; Zhu G; Huang Z; Cao L; Chen Y; Wang Q; Zhang X
    Hybridoma (Larchmt); 2012 Dec; 31(6):417-23. PubMed ID: 23244320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unconventional ligand activation of herpesvirus entry mediator signals cell survival.
    Cheung TC; Steinberg MW; Oborne LM; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6244-9. PubMed ID: 19332782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.
    del Rio ML; Jones ND; Buhler L; Norris P; Shintani Y; Ware CF; Rodriguez-Barbosa JI
    J Immunol; 2012 May; 188(10):4885-96. PubMed ID: 22490863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding.
    Spodzieja M; Kuncewicz K; Sieradzan A; Karczyńska A; Iwaszkiewicz J; Cesson V; Węgrzyn K; Zhukov I; Maszota-Zieleniak M; Michielin O; Speiser DE; Zoete V; Derré L; Rodziewicz-Motowidło S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
    Gertner-Dardenne J; Fauriat C; Orlanducci F; Thibult ML; Pastor S; Fitzgibbon J; Bouabdallah R; Xerri L; Olive D
    Blood; 2013 Aug; 122(6):922-31. PubMed ID: 23692853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
    Cheung TC
    Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.
    Spodzieja M; Lach S; Iwaszkiewicz J; Cesson V; Kalejta K; Olive D; Michielin O; Speiser DE; Zoete V; Derré L; Rodziewicz-Motowidło S
    PLoS One; 2017; 12(6):e0179201. PubMed ID: 28594868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator.
    Nelson CA; Fremont MD; Sedy JR; Norris PS; Ware CF; Murphy KM; Fremont DH
    J Immunol; 2008 Jan; 180(2):940-7. PubMed ID: 18178834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses.
    Lasaro MO; Tatsis N; Hensley SE; Whitbeck JC; Lin SW; Rux JJ; Wherry EJ; Cohen GH; Eisenberg RJ; Ertl HC
    Nat Med; 2008 Feb; 14(2):205-12. PubMed ID: 18193057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M; Sedy J; Nelson CA; Murphy KM
    Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.
    Jones A; Bourque J; Kuehm L; Opejin A; Teague RM; Gross C; Hawiger D
    Immunity; 2016 Nov; 45(5):1066-1077. PubMed ID: 27793593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Balancing co-stimulation and inhibition with BTLA and HVEM.
    Murphy KM; Nelson CA; Sedý JR
    Nat Rev Immunol; 2006 Sep; 6(9):671-81. PubMed ID: 16932752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct Changes of BTLA and HVEM Expressions in Circulating CD4
    Liu J; Li J; He M; Zhang GL; Zhao Q
    J Immunol Res; 2018; 2018():4561571. PubMed ID: 30116751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction.
    Shubin NJ; Chung CS; Heffernan DS; Irwin LR; Monaghan SF; Ayala A
    J Leukoc Biol; 2012 Sep; 92(3):593-603. PubMed ID: 22459947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex.
    Compaan DM; Gonzalez LC; Tom I; Loyet KM; Eaton D; Hymowitz SG
    J Biol Chem; 2005 Nov; 280(47):39553-61. PubMed ID: 16169851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cloning and characterization of TNFSF14 (LIGHT) and its receptor TNFRSF14 (HVEM) in guinea pig (Cavia porcellus).
    Li C; Chen S; Song J; Liu H; Gu W; Ai H; Zhao B; Zhang S
    Gene; 2013 Sep; 526(2):374-84. PubMed ID: 23732292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.
    Thibult ML; Rivals JP; Mamessier E; Gertner-Dardenne J; Pastor S; Speiser DE; Derré L; Olive D
    J Mol Med (Berl); 2013 Feb; 91(2):195-205. PubMed ID: 22903545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.